XML 133 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Equity-Based Compensation (Tables)
12 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan The compensation cost for employee and non-employee director equity-based compensation programs for all current and prior year awards granted are as follows:
202320222021
Stock appreciation rights$1,584 $2,370 $2,345 
Performance-based restricted stock units2,479 1,718 1,151 
Time vested restricted stock units2,461 1,423 602 
Restricted stock awards1,102 850 730 
Employee stock purchase plan2,956 2,521 2,633 
Total compensation cost before income taxes$10,582 $8,882 $7,461 
Income tax benefit$1,156 $970 $893 
Schedule of Nonvested PSU Activity PSUs are as follows:
Performance-Based Restricted Stock UnitsNumber of AwardsWeighted-
Average
Grant Date Fair Value
Nonvested at October 1, 202258,444 $78.41 
Granted in 202340,949 85.17 
Vested in 2023(27,077)73.39 
Forfeited in 2023(2,417)80.29 
Nonvested at September 30, 202369,899 $84.25 
Schedule of Nonvested TVA Activity
TVAs are as follows:
Time Vested Restricted Stock UnitsNumber of AwardsWeighted-
Average
Fair Value
Nonvested at October 1, 202254,559 $71.40 
Granted in 202339,920 85.17 
Vested in 2023(17,768)86.21 
Forfeited in 2023(1,220)105.13 
Decrease due to fair value change in 2023(25,446)n/a
Nonvested at September 30, 202350,045 $112.72 
Schedule of Employee Stock Purchase Plan Activity
Shares and the weighted-average price per share associated with the ESPP are as follows:
Employee Stock Purchase Plan202320222021
Shares issued155,704 139,121 141,647 
Weighted-average price per share$70.91 $67.91 $58.52 
Schedule Of Range Of Assumptions Used To Value Equity-Based Awards And The Weighted-Average Fair Value Of The Awards Granted The following table provides the range of assumptions used to value awards and the weighted-average fair value of the awards granted.
20222021
Expected volatility39% - 40%38% - 41%
Risk-free rate1.3 %0.4% - 0.5%
Expected dividends1.2 %1.4 %
Expected term5-6 years5-6 years
Weighted-average fair value of awards granted$27.86 $23.11 
Schedule of Stock Appreciation Rights Activity SARs are as follows:
Stock Appreciation RightsNumber of AwardsWeighted-
Average
Exercise Price
Weighted-
Average
Remaining Contractual Life
Aggregate
Intrinsic
Value
Outstanding at October 1, 2022858,503 $73.67 
Exercised in 2023(152,698)57.85 
Expired in 2023(1,736)85.95 
Forfeited in 2023(2,559)79.59 
Outstanding at September 30, 2023701,510 $77.06 4.7 years$25,045 
Exercisable at September 30, 2023614,012 $76.66 4.2 years$22,169 
Schedule Of Intrinsic Value Of Awards Exercised And Fair Value Of Awards Vested The intrinsic value of awards exercised and fair value of awards vested are as follows:
Stock Appreciation Rights202320222021
Intrinsic value of SARs exercised$5,596 $3,777 $3,833 
Total fair value of SARs vested$2,426 $2,346 $2,558